Previous Article | Next Article 
The Journal of Neuroscience, October 1, 2001, 21(19):7674-7683
Volume-Activated Chloride Currents Contribute to the Resting
Conductance and Invasive Migration of Human Glioma Cells
Christopher B.
Ransom,
Jeffrey T.
O'Neal, and
Harald
Sontheimer
Department of Neurobiology, University of Alabama at Birmingham,
Birmingham, Alabama 35294
 |
ABSTRACT |
We used an in vitro model for glioma cell invasion
(transwell migration assay) and patch-clamp techniques to investigate
the role of volume-activated Cl
currents
(ICl,Vol) in glioma cell invasion.
Hypotonic solutions (
230 mOsm) activated outwardly rectifying
currents that reversed near the equilibrium potential for
Cl
ions (ECl).
These currents (ICl,Vol) were
sensitive to several known Cl
channel inhibitors,
including DIDS, tamoxifen, and 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB). The IC50 for NPPB inhibition of
ICl,Vol was 21 µM. Under isotonic conditions, NPPB (165 µM) blocked inward
currents (at
40 mV) and increased input resistance in both standard
whole-cell recordings and amphotericin perforated-patch recordings.
Reducing [Cl
]o under isotonic
conditions positively shifted the reversal potential of whole-cell
currents. These findings suggest a significant resting Cl
conductance in glioma cells. Under isotonic and
hypotonic conditions, Cl
channels displayed
voltage- and time-dependent inactivation and had an
I
> Cl
permeability. To
assess the potential role of these channels in cell migration, we
studied the chemotactic migration of glioma cells toward laminin or
vitronectin in a Boyden chamber containing transwell filters with 8 µm pores. Inhibition of ICl,Vol with NPPB
reduced chemotactic migration in a dose-dependent fashion with an
IC50 of 27 µM. Time-lapse video microscopy
during patch-clamp recordings revealed visible changes in cell shape
and/or movement that accompanied spontaneous activation of
ICl,Vol, suggesting that
ICl,Vol is activated during cell movement,
consistent with the effects of NPPB in migration assays. We propose
that ICl,Vol contributes to cell shape and
volume changes required for glioma cell migration through brain tissue.
Key words:
brain tumor; volume regulation; Cl
channels; ion channels; neuro-oncology; extracellular matrix
 |
INTRODUCTION |
Chloride channels are ubiquitous
transmembrane proteins involved in diverse cellular processes. They are
essential for salt and fluid movements across epithelia (Venglarik et
al., 1990
; O'Grady et al., 2000
), volume regulation (Jackson and
Madsen, 1997
; Valverde, 1999
), and they contribute to the proliferation of some cell types (Wilson and Chiu, 1993
; Pappas and Ritchie, 1998
;
Shen et al., 2000
). We previously proposed that the invasive migration
of human glioma cells requires shape and/or volume changes (Soroceanu
et al., 1999
). Chloride currents may contribute to such shape-volume
changes by affecting net salt fluxes across glioma membranes. We
hypothesize that salt efflux, with its accompanying water efflux,
results in cell shrinkage that is conducive to glioma cell migration
through the minute extracellular spaces of brain. Hence, chloride
channels may aid the invasive biology of glioma cells, a feature that
greatly compromises surgical treatment of this disease (Adams and
Victor, 1989
).
Recently, a significant effort has gone into the molecular
identification of diverse chloride channels (Valverde, 1999
; Maduke et
al., 2000
). However, one of the most ubiquitously expressed channels,
the one mediating volume-activated chloride currents (ICl,Vol), has been elusive. Although
some studies suggest that ICl,Vol is
mediated by ClC-3 Cl
channels (Duan et
al., 1997
, 1999
; Wang et al., 2000
), a recent study found no deficit of
volume-activated chloride currents in hepatocytes from ClC-3 knock-out
mice (Stobrawa et al., 2001
). In spite of the difficulties concerning
the molecular identification of
ICl,Vol, there is good agreement on
the properties of endogenous volume-activated chloride currents (Rasola
et al., 1992
; Diaz et al., 1993
; Pollard, 1993
; Bond et al., 1998a
;
Duan et al., 1999
; Von Weikersthal et al., 1999
; Shen et al.,
2000
). Hallmark properties of these currents include slight
outward-rectification, time- and voltage-dependent inactivation at
positive potentials, and block by tamoxifen,
5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB), DIDS, and
Zn2+. In addition,
ICl,Vol has a halide selectivity
sequence of I
> Br
> Cl
> F
(Rasola et al., 1992
; Diaz et al.,
1993
; Bond et al., 1998a
; Duan et al., 1999
; Von Weikersthal et al.,
1999
; Shen et al., 2000
).
ICl,Vol is believed to be essential
for volume regulation of cells, particularly after cell swelling with
hypotonic solutions (Jackson and Madsen, 1997
; Rouzaire-Dubois et al.,
1999
; Valverde, 1999
; Wang et al., 2000
). The activation of
ICl,Vol by volume changes and its
influence on cell volume make it a prime candidate for participation in
the shape-volume changes that glioma cells undergo during invasive
migration (Soroceanu et al., 1999
). We used patch-clamp techniques to
investigate Cl
currents in human glioma
cells and an in vitro model of invasive migration (transwell
migration assay) to evaluate their role in invasion. We find that the
resting conductance of human glioma cells is dominated by chloride
channels with a pharmacology consistent with that of
ICl,Vol. Furthermore, inhibitors of
ICl,Vol block the migration of glioma cells.
 |
MATERIALS AND METHODS |
Cell culture. All experiments were performed on the
glioma cell lines STTG-1 (anaplastic astrocytoma, WHO grade III;
American Type Tissue Collection, Rockville, MD) and D54MG (glioblastoma multiforme, WHO grade IV; Dr. D. Bigner, Duke University, Durham, NC). Cells were maintained in DMEM (Life Technologies,
Grand Island, NY) with 10% fetal calf serum (Hyclone, Logan, UT).
Cells were kept in an incubator (Lab-Line Instruments, Melrose Park,
IL) at 37°C in a 90% O2/10%
CO2 humidified environment.
Electrophysiology. Standard patch-clamp techniques were used
to record whole-cell membrane currents (Hamill et al., 1981
). Patch pipettes were pulled on an upright puller (PP-83; Narishige, Tokyo, Japan) from thin-walled, glass capillary tubing with filament (MTW150F-4; WPI, Sarasota, FL) and had resistances of 3-5 M
. For
experiments with amphotericin B (Sigma, St. Louis, MO) perforated patches, we closely followed the procedures of Rae et al.
(1991)
. Pipettes used for amphotericin perforated-patch
recording were fire-polished on a microforge (MF-83, Narishige) and had
resistances of 1-3 M
. Inclusion of Lucifer yellow (Sigma) in our
pipette solutions for amphotericin perforated-patch recordings allowed us to distinguish perforated-patch recordings from whole-cell recordings (fluorescence rapidly appeared in cells after breakthrough). We used an Axopatch 200B amplifier (Axon Instruments, Redwood City, CA)
controlled by a PC-compatible microcomputer (Dell Computers, Dallas,
TX) running Axon Instruments software (pClamp7). Data were stored
directly to disk using a Digidata 1200 A-D interface (Axon
Instruments). Data were acquired at 10 kHz and filtered at 2 kHz.
Capacitance and series resistance, Rs,
compensation was performed with the Axopatch amplifier.
Rs was compensated up to 80%. No
post hoc correction of Rs
was performed. Experiments were not performed on cells with a
Rs > 10 M
(except with
amphotericin perforated patches). Cells were visualized with an
inverted microscope (Nikon, Melville, NY). The recording chamber had a
volume of
300 µl and was constantly superfused with control
extracellular solution at a rate of
0.5 ml/min. A triple-barreled
microperfusion device with a stepper motor (SF-77B perfusion fast-step;
Warner Instruments, Hamden, CT) was used to apply test solutions
directly to cells. Grounding the recording chamber via an agar salt
bridge (4% agar, 1 M KCl) minimized liquid
junction potentials produced by test solutions.
Solutions. Our standard bath solution contained the
following (in mM): 5 KCl, 135 NaCl, 1.6 Na2HPO4, 0.4 NaH2PO4, 1 MgSO4, 10 glucose, 32.5 HEPES (acid). pH was
adjusted to 7.4 with NaOH. Osmolarity was tested with a vapor pressure
osmometer (Wescor 5500; Wescor, Logan, UT). The osmolarity of control
bath solution was
300 mOsm. Solutions were made hypotonic by mixing
control bath solution with bath solution with no added NaCl. Drugs were added directly to these solutions. Cl
currents were
isolated pharmacologically by adding 1-10 mM
tetraethylammonium ion (TEA) to our bath solution to inhibit the big
conductance K (BK) channels in these cells (Fig. 3). Our standard
pipette solution contained (in mM): 145 CsCl, 1 MgCl2, 10 HEPES (acid), and 10 EGTA. We used
KCl-based pipette solutions for perforated-patch experiments and when
we pharmacologically isolated chloride currents. pH was adjusted
to 7.25 with Tris-base. All chemicals were purchased from Sigma unless
otherwise noted.
Transwell migration assays. To assess chloride current
involvement in glioma cell migration, we performed transwell migration assays, an in vitro model for invasive migration. Briefly,
cells were plated on top of a culture plate insert (Becton Dickinson, Rutherford, NJ). The insert consists of a filter with 8 µm pores that
cells must navigate to cross to the bottom side of the transwell filter. Assays were run for
4 hr in serum-free culture media (DMEM)
at 37°C in a humidified 90% O2/10%
CO2 environment. After this time, cells were
fixed with paraformaldehyde and stained with crystal violet. Cells were
wiped away from the top of transwell filters before counting cells on
the bottom (i.e., those cells that have migrated across the filter).
Cells were counted immediately after staining or were stored at 4°C
in PBS. We used a Leica DMRB microscope (Vashau Scientific,
Atlanta, GA) to count cells. An investigator blinded to the identity of
the transwell filter counted cells from four random fields. A digital
CCD camera connected to an IBM-compatible PC (Dell Computers) was used
to capture images of the bottom of transwell filters. Drugs were added
to both sides of the filter 1 hr after plating cells. The bottoms of
filters were coated with extracellular matrix (ECM) by a 24 hr
incubation in PBS with 10 µg/ml laminin or vitronectin in PBS (Sigma)
or mock-coated with 0.1% bovine serum albumin.
Analysis. Data were analyzed off-line with the software
package Origin (v.5.0; Microcal Software, Northhampton, MA). All
curve-fitting was performed using a least-squares curve-fitting routine
provided by the software. Inhibition curves were fit with the following equation:
|
(1)
|
where I/Imax is the
fractional remaining current, IC50 is the
half-maximal inhibitory concentration, and n is the Hill
slope. We calculated input resistance
(Rin) with voltage steps from
40 to
60 mV, as follows:
|
(2)
|
I
40
60 mV is the
steady-state current change that is produced by a voltage step from
40 to
60 mV. The relative permeability of iodide to chloride for
whole-cell currents under isotonic and hypotonic conditions
(PI/PCl)
was calculated from shifts in reversal potential
(
Erev) with the constant field
equation (Hille, 1992
), as follows:
|
(3)
|
Erev is the shift in
reversal potential seen from switching the bathing solution from the
initial extracellular Cl
concentration,
[Cl
]o, to a
solution with an extracellular I
concentration,
[I
]o. zF/RT was
0.017 under our conditions.
Statistical analysis was performed with Excel (Microsoft, Bellevue,
WA). We used a two-tailed t test to evaluate data for statistical significance with an
value of p < 0.05 (p values are given in Results).
 |
RESULTS |
Volume-activated Cl currents
We hypothesize that Cl
currents are
activated during the migration of human glioma cells, periods during
which these cells undergo shape and/or volume changes. Volume-activated
Cl
currents
(ICl,Vol), those currents activated by
cell-swelling with hypotonic solutions, are likely candidates to
fulfill this role. We began our study by examining the properties of
the volume-activated Cl
currents in
human glioma cells. We performed experiments on two well characterized
glioma cell lines, D54MG (glioblastoma multiforme) and STTG1
(anaplastic astrocytoma). Glioma cells exposed to hypotonic solutions
rapidly (within 10-20 sec) activated currents that reversed near the
equilibrium potential for Cl
ions
(ECl was +2 mV under hypotonic
conditions) (Fig.
1A,B). The activation of these currents by hypotonic solutions was accompanied by visible cell-swelling that was reversible on return to control solutions. Hypotonicity-induced currents were readily activated by a
change in osmolarity from 300 to 260 mOsm and gave a graded response to
the hypotonic challenge. The peak current densities (at
40 mV) were
0.32 ± 0.6,
22 ± 10, and
62 ± 21 pA/pF with
300 mOsm (control conditions),
260 mOsm, and
200 mOsm,
respectively (mean ± SD, n = 3-12 cells).
Currents activated by hypotonic challenge were >80% inhibited by
external application of several well known antagonists of
ICl,Vol, including NPPB (165 µM), tamoxifen (10 µM),
DIDS (100 µM), and
Zn2+ (1 mM).
Examples of reversible block of hypotonicity-induced currents by NPPB
and tamoxifen are shown in Figure 1. NPPB effects reversed faster than
those of tamoxifen. For this reason, we preferred the use of NPPB to
achieve potent, voltage-independent block of these currents. At the end
of a hypotonic challenge, a sharp increase in outward current was
transiently seen, consistent with these currents being
Cl
currents (from hypotonic solution to
control, [Cl
]o
goes from 83 to 138 mM) (Fig.
1A,C). In addition, increasing [Cl
]o during the
return to isotonic bath negatively shifted the reversal potential of
these currents (Fig. 1D). The magnitude of these shifts compared well to those predicted for a pure
Cl
current (Fig. 1E).
The volume sensitivity, pharmacology, and [Cl
]o dependence
of these currents strongly suggest they represent ICl,Vol, similar to
ICl,Vol described in other human
preparations, including different glioma cell lines (Rasola et al.,
1992
; Bakhramov et al., 1995
).

View larger version (32K):
[in this window]
[in a new window]
|
Figure 1.
Glioma cells rapidly activate
Cl currents after exposure to hypotonic solutions.
A, Time course of current activation by hypotonic
solutions and block by NPPB (165 µM). Horizontal
bars indicate period of solution change in this and subsequent
figures. B, Current responses to voltage ramps
(from the experiment in A at time points indicated with
a-c). C, Time course of current activation
by hypotonic solutions and block by tamoxifen (10 µM). D, Current responses to voltage
ramps before and after return to isotonic solution (a change in
[Cl ]o from 83 to 138 mM). The reversal potential shifts negatively when
[Cl ]o is increased, consistent with
a Cl current. Letters in time
courses correspond to the traces in
D. E, Summary of shifts in
reversal potential at the end of hypotonic exposure. These shifts
compare well with those predicted by the Nernst equation for a pure
Cl current.
|
|
Volume-activated Cl
currents have been
shown to be regulated by tyrosine kinases (Sorota, 1995
; Crepel et al.,
1998
), serine-threonine kinases (Duan et al., 1999
), protein
phosphatases (Duan et al., 1999
), and
Ca2+-dependent depolymerization of actin
(Lascola and Kraig, 1998
; Lascola et al., 1998
). We examined the
biochemical mechanisms underlying hypotonicity-induced activation of
ICl,Vol in D54MG glioma cells by
including drugs in our pipette solution and allowing a 5 min delivery
period after obtaining a whole-cell recording that was followed by a 5 min exposure to solution with an osmolarity of
200 mOsm. Drugs were
added to the pipette solution at concentrations 10- to 15-fold higher
than the IC50 to improve diffusional delivery to
the cytoplasm. Inclusion of ATP (2 mM) and GTP (1 mM) in our pipette solutions did not
significantly modify the peak current density or rate of activation of
ICl,Vol during application of hypotonic bath solution. Peak current density at
40 mV was
59 ± 10 and
64 ± 28 pA/pF with intracellular ATP/GTP
(n = 3) and for same-coverslip control cells
(n = 8), respectively. We performed experiments with
genistein (to inhibit tyrosine kinases; 25 µM), staurosporine (to inhibit serine-threonine kinases; 120 nM), and phalloidin (to prevent depolymerization
of actin; 1.3 µM). We also performed
experiments with 0 extracellular Ca2+ and
10 mM intracellular BAPTA to prevent
intracellular Ca2+ rises during hypotonic
exposure. None of these manipulations prevented
ICl,Vol activation or significantly
altered the peak current density of
ICl,Vol compared with same-coverslip
controls. The mean values for peak current density (pA/pF at
40 mV)
were
41 ± 13 (n = 7),
54 ± 13 (n = 3; p = 0.21),
32 ± 25 (n = 4; p = 0.55), and
34 ± 25 (n = 7; p = 0.57) for control
conditions, genistein, staurosporine, and phalloidin, respectively. The
peak current density with 0 added extracellular
Ca2+ and 10 mM
intracellular BAPTA was
41 ± 14 pA/pF (n = 3;
p = 0.99). The inability to block
ICl,Vol activation pharmacologically is suggestive of mechanical activation of
Cl
channels after cell-swelling with
hypotonic solution. Intriguingly, mechanosensitive
Cl
channels blocked by NPPB have been
reported in neuronal growth cones (Imai et al., 2000
).
Cl
currents under isotonic conditions
Our pharmacologic experiments on
ICl,Vol showed that the current
remaining in the presence of 165 µM NPPB or 10 µM tamoxifen was smaller than the control
current before cell swelling (Fig. 1C), suggesting that
glioma cells have a resting Cl
conductance under isotonic conditions. We studied this resting Cl
conductance with two approaches; we
substituted extracellular Cl
with poorly
permeant anions (glutamate
and
gluconate
) and pharmacologically
inhibited the resting Cl
conductance
(Fig. 2). Figure 2A
shows a representative experiment in which
Cl
was substituted with
glutamate
under isotonic conditions.
Cl
-substitution with poorly permeant
(glutamate
or
gluconate
) anions resulted in a
reduction of outward currents and a positive shift in reversal
potential. Both of these results are consistent with a resting
Cl
conductance under isotonic
conditions. In addition, ICl,Vol
antagonists significantly increased the input resistance
(Rin) of glioma cells under isotonic
conditions (Fig. 2B). Figure 2C summarizes
the effects of the ICl,Vol antagonists
NPPB and tamoxifen on Rin of glioma
cells under isotonic conditions. On average, NPPB increased input
resistance by 90%.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 2.
Glioma cells have a resting chloride conductance
under isotonic conditions. A, Current responses to
voltage ramps in a D54MG cell with control bath solution (135 mM [Cl ]o) and
Na-glutamate bath solution (5 mM
[Cl ]o).
[Cl ]o substitution with poorly
permeant anions positively shifted the reversal potential of whole-cell
currents. [Cl ]o substitution
primarily affected the outward currents, as expected if
Cl was contributing to these currents. Pipette and
bath solutions were isotonic. B, The
ICl,Vol inhibitor NPPB inhibited resting
inward currents and increased the input resistance of cells under
isotonic conditions. Inset shows current responses
before and after application of NPPB (0.16 mM) to voltage
steps from 40 to 60 mV. C, Summary of the effects of
the ICl,Vol inhibitors tamoxifen and NPPB on
the input resistance (Rin) of D54MG
cells under isotonic conditions.
|
|
Time- and voltage-dependent inactivation at positive voltages is
another feature of volume-activated Cl
currents described for many cell types, including astrocytes (Lascola
et al., 1998
), endothelial cells (Von Weikersthal et al., 1999
),
Caco-2 cells (Trouet et al., 1999
), colonic carcinoma cells (Worrell et
al., 1989
), and other human glioma cells (Bakhramov et al., 1995
). We
also observed this voltage-dependent activation for
hypotonicity-induced currents (data not shown).
Cl
currents pharmacologically isolated
under isotonic conditions (tetraethylammonium ion to block BK currents)
(Ransom and Sontheimer, 2001
) or with CsCl pipette solutions showed all
the hallmarks of ICl,Vol. These
include reversal near ECl, time- and
voltage-dependent inactivation, and slight outward rectification (Fig.
3). We were able to infer that the
inactivating currents represent those active at rest because voltage
steps that caused inactivation (>+60 mV) resulted in a decrease in the
holding current (at
40 mV). The degree of inactivation of currents
evoked with voltage steps was in excellent quantitative agreement with
the inactivation of holding currents (at
40 mV). For the records in
Figure 3C, the ratio of the current at the end of the
voltage step to the peak current was 0.36, and the ratio of holding
current after to the holding current before the voltage step was 0.44. We did not examine the time course of recovery from inactivation in
detail but the reduction in holding current after voltage-dependent
inactivation of Cl
channels completely
recovered within 10 sec.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 3.
Kinetics of Cl currents under
isotonic conditions. A, Whole-cell currents evoked with
voltage steps from 120 to +160 mV from a holding potential of 40 mV
before and after application of tetraethylammonium ion (TEA, 10 mM). KCl pipette solution. B,
I-V plot of the steady-state currents
under control conditions and with TEA. TEA blocks the BK currents
present in these cells (Ransom and Sontheimer, 2001 ). C,
TEA-insensitive currents evoked with voltage steps to +40 and +120 mV
(Vh of 40 mV). At potentials greater than
+100 mV, TEA-insensitive currents displayed inactivation. This
voltage-dependent inactivation resulted in a reduction in the holding
current ( 40 mV; arrow). The degree of inactivation of
currents evoked with voltage steps was in excellent quantitative
agreement with that seen for holding currents ( 40 mV).
|
|
Volume-activated Cl
channels have been
shown to be regulated by intracellular ATP,
Ca2+, tyrosine kinases,
serine-threonine kinases, protein phosphatases, and
cytoskeletal actin (Sorota, 1995
; Crepel et al., 1998
; Lascola et al., 1998
; Duan et al., 1999
). An important issue regarding the resting Cl
conductance is whether
cell dialysis during whole-cell recordings subtly alters cell volume or
channel regulation, leading to some basal activation. We addressed
these concerns by obtaining amphotericin perforated patches from our
glioma cells and extracellularly applying the
ICl,Vol antagonist NPPB (Fig.
4). As seen with conventional whole-cell
recordings, NPPB increased the input resistance in nondialyzed cells.
In perforated-patch-clamped cells, Rin
was 155 ± 92 and 256 ± 102 M
(65% increase) under
control conditions and with 165 µM NPPB,
respectively (p < 0.05; n = 10). Most importantly, NPPB always blocked an inward current in
perforated-patch-clamped cells at typical resting potentials (
40 mV)
(Fig. 4C). This last result indicates that glioma cells
actively regulate
[Cl
]i such that
ECl is positive to the resting
potential leading to Cl
efflux at the
resting potential. The larger input resistances in our whole-cell
recordings compared with perforated-patch recordings are
likely caused by inhibition of K+
currents by the CsCl pipette solutions. In perforated-patch
experiments, we observed no effect of 1 mM TEA on
currents at
40 mV or on input resistance. TEA and NPPB are therefore
acting on distinct ionic conductances.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 4.
The resting chloride conductance of glioma cells
is present in nondialyzed cells (amphotericin perforated-patch clamp).
A, Double y-axis plot of current (at 40
mV) and input resistance (Rin) as a
function of time in an amphotericin perforated-patch-clamped cell. NPPB
(165 µM), but not TEA (1 mM), blocked an
inward current at typical resting potentials ( 40 mV) and increased
the input resistance. Inset shows current responses to a
voltage step from 40 to 60 mV before and after NPPB application
(used to calculate input resistance). The series resistance of this
cell was 22 M . B, Summary of NPPB effects on input
resistance in cells recorded from in the perforated-patch
configuration. C, Summary of NPPB effects on current at
40 mV in cells recorded from in the perforated-patch configuration.
Data in B and C are displayed as
mean ± SE.
|
|
Results presented thus far suggest that (1) glioma cells are endowed
with ICl,Vol and (2)
ICl,Vol is constitutively active under
isotonic conditions. We examined one other hallmark of
ICl,Vol, namely an
I
> Cl
selectivity (Rasola et al., 1992
; Diaz et al., 1993
; Pollard, 1993
;
Duan et al., 1997
; Bond et al., 1998a
; Von Weikersthal et al., 1999
),
to evaluate whether the currents active at rest represent the same
currents activated with hypotonicity.
Relative iodide permeability of ICl,Vol
and resting Cl currents
If ICl,Vol underlies the resting
Cl
conductance in glioma cells, the
whole-cell currents under isotonic and hypotonic conditions should have
the same selectivity sequence. We examined the relative permeability of
I
to Cl
for both the resting Cl
conductance and
hypotonicity-induced currents (Rasola et al., 1992
; Diaz et al., 1993
;
Pollard, 1993
; Duan et al., 1997
; Bond et al., 1998a
; Von Weikersthal
et al., 1999
). Replacement of NaCl with NaI under isotonic conditions
increased outward current amplitude and negatively shifted the reversal
potential of whole-cell currents (Table
1). Activation of currents with hypotonic
solution followed by application of hypotonic solution with NaI
replacing NaCl similarly increased outward currents and negatively
shifted reversal potentials. Calculation of the relative permeability
of I
to
Cl
(PI/PCl)
with the Goldman-Hodgkin-Katz equation suggested a
PI/PCl of 1.6 for whole-cell currents under isotonic and hypotonic conditions. The liquid junction potential produced by a change from 140 [Cl
]o to 135 [I
]o was
determined to be approximately
1 mV. The values in Table 1
were not corrected for this.
Inhibition of glioma cell migration by NPPB
We evaluated the participation of chloride currents in glioma cell
migration by performing transwell migration assays, an in
vitro model for invasive migration (see Materials and
Methods). These assays involve plating cells on the top of a
culture plate insert with a filter consisting of 8 µm pores,
providing three-dimensional constraints on migrating cells. Cells must
change their shape to navigate these pores and cross to the bottom of
the filter. In the absence of ECM (mock coating of filter with
bovine serum albumin), essentially no directional cell movement across
the transwell filter was observed (Fig.
5A). Coating the bottom of the
filter with ECM potently increased directional, chemotactic migration
of glioma cells to the bottom of the transwell filter. This enhanced
migration in the presence of ECM was abrogated by NPPB. For the
experiment in Figure 5, 30 µM NPPB reduced
transwell migration by 62%. If NPPB is reducing migration by
inhibiting volume-activated Cl
currents,
NPPB inhibition of migration and of volume-activated Cl
currents is predicted to have a
similar concentration dependence. We determined dose-response
relationships for NPPB inhibition of volume-activated
Cl
currents and for transwell migration
assays (Fig. 6). Plotting normalized
volume-activated Cl
current as a
function of NPPB concentration and fitting these data with a Langmuir
binding isotherm (Materials and Methods) suggested an
IC50 of 21 µM (Fig.
6B). The concentration dependence of NPPB inhibition
of transwell migration was in excellent agreement with patch-clamp data
for volume-activated Cl
currents. The
solid line in Figure 6B is the fit to patch-clamp data. We also fit transwell migration data with the same equation and
obtained an IC50 of 27 µM. These results support the hypothesis that
volume-activated Cl
currents are
activated during, and contribute to, the migration of human glioma
cells. Data in Figures 5 and 6 are from D54MG cells, but we obtained
similar results with two other glioma cell lines (U373MG and STTG1).
Our data agrees with previous studies showing that tamoxifen inhibited
glioma cell migration (Soroceanu et al., 1999
). NPPB effects could be
reversed after 4 hr of exposure by exchanging the solutions on top and
bottom of the transwell filter insert (data not shown).

View larger version (58K):
[in this window]
[in a new window]
|
Figure 5.
Transwell migration is inhibited by the
ICl,Vol antagonist NPPB.
A-C, Photomicrographs of the bottom of a transwell
filter (8 µm pores) coated with bovine serum albumin (BSA;
1%) (A), the extracellular matrix
(ECM) molecule vitronectin
(B), and vitronectin plus 30 µM
NPPB (C). Vitronectin stimulates migration that
is sensitive to NPPB. D, Summary of the experiment
illustrated in A-C. Data are presented as mean ± SE of four transwell filters from a single experiment.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Figure 6.
Dose dependence of NPPB inhibition of
ICl,Vol and transwell migration.
A, Representative current traces in response to voltage
ramps in a cell exposed to hypotonic solution with increasing NPPB
concentrations. Note negative shift in reversal potential as
Cl currents are blocked. B, Double
y-axis plot of NPPB inhibition of
ICl,Vol and transwell migration. The
solid line is a binding isotherm. The data for NPPB
inhibition of transwell migration agreed well with
ICl,Vol data. Data points are mean ± SE from three to seven experiments.
|
|
Spontaneous activation of ICl,Vol
In the absence of hypotonic stimulation, the majority of cells did
not display significant changes in input resistance during the
recording period (up to 30 min). However, there were examples of
spontaneously developing currents during whole-cell recordings. These
spontaneously activating currents were roughly linear and sensitive to
NPPB. To determine whether these spontaneously activating currents were
associated with changes in cell shape or size, we made time-lapse video
recordings of cells during whole-cell recording. We obtained examples
of clear, unidirectional movement in glioma cells, and this movement
was invariably associated with an increase in whole-cell currents
across a range of potentials (Fig. 7). The cell shown in Figure 7A-D began to extend a
leading process after
3 min of whole-cell recording (acquisition was
begun
2 min after obtaining a whole-cell recording). Over the next
several minutes, this process (Fig. 7A-D,
white arrow) continued to extend and broaden. Contraction of
the trailing process in the upper left-hand corner can be appreciated
in the final frame (Fig. 7D). Currents progressively
increased during these events (Fig. 7E). Currents activated
during movement could be distinguished from nonspecific leak associated
with loss of giga-seal integrity by their sensitivity to NPPB. Movement
ceased after application of NPPB to the cell in Figure 7. However, it
is impossible for us to know how far these events would have progressed
in the absence of NPPB. In addition, we do not predict NPPB to have any
effects on cell motility under these conditions because
tamoxifen, another ICl,Vol antagonist,
has no effect on the two-dimensional migration of glioma cells
(Soroceanu et al., 1999
). Activation of currents during movement
was accompanied by positive shifts in reversal potential, consistent
with the pharmacologic identification of these currents as
Cl
currents. We observed spontaneous
activation of Cl
currents (>25% change
in input resistance) in 4 of 15 cells from which we obtained
simultaneous whole-cell recordings and time lapse video images.
Spontaneous activation was invariably associated with changes in cell
shape and movement. One concern regarding these experiments is whether
the patch pipette itself could have introduced membrane stress or
modified the cytoskeleton, thereby leading to channel activation. Given
the low frequency of spontaneous activation of
Cl
currents (<30%), we do not believe
this to be the case. These experiments were performed with KCl pipette
solutions in the absence of TEA.

View larger version (55K):
[in this window]
[in a new window]
|
Figure 7.
Cell movement is accompanied by spontaneous
activation of ICl,Vol.
A-D, Sequential photomicrographs of a
D54MG cell. Times indicate when the photomicrographs were taken after
obtaining a whole-cell recording. E, Time course of
current change in this cell. Letters correspond to the
photomicrographs in A-D. Currents
pharmacologically consistent with ICl,Vol
(NPPB-sensitive) were activated as the cell began to extend a leading
process and contracted its trailing edge. Data acquisition was begun
125 sec after establishing a whole-cell recording. F,
Ramp currents from the data in E. Letters
correspond to the time points in E.
|
|
 |
DISCUSSION |
Our experiments demonstrate that chloride channels mediate a
substantial portion of the resting conductance of D54MG and STTG-1 glioma cells. Drugs that inhibit these
Cl
channels abrogated migration of
glioma cells in vitro. Resting Cl
currents were present in nondialyzed
cells (amphotericin perforated patches) indicating that these were not
a result of cellular perturbations during whole-cell recordings. The
channels that mediate the resting conductance in glioma cells have not
been identified. However, we believe that they resemble
volume-activated Cl
channels for the
following reasons: (1) resting currents and volume-activated currents
shared the same pharmacology, (2) currents under isotonic and hypotonic
conditions displayed similar time- and voltage-dependent inactivation,
and (3) resting Cl
channels and
volume-activated channels both have an iodide > chloride permeability.
The prominent resting Cl
conductance in human glioma cells is in sharp contrast to the situation
in "normal" rodent glia in which a large resting
K+ conductance predominates
(Kettenmann et al., 1983
; Ransom and Sontheimer, 1995
;
Bordey and Sontheimer, 1997
). The latter is mediated by
inwardly rectifying K+ channels (Newman,
1993
; Ransom and Sontheimer, 1995
; Kofuji et al., 2000
) that were not
observed in D54MG glioblastoma cells (see however Brismar and Collins,
1988
; Bakhramov et al., 1995
). The resting chloride conductance
can account for the relatively positive resting membrane potentials of
the glioma cells in our study (
50 to
10 mV) (Ullrich and
Sontheimer, 1996
; Ransom and Sontheimer, 2001
). Moreover, similar
membrane potentials have been reported for human glioblastoma cells
in situ (Picker et al., 1981
; Ullrich et al., 1998
). Other
actively proliferating cells also maintain relatively positive resting
membrane potentials (Cone, 1970
). Interestingly, neuroblastoma cells
and colonic carcinoma cells also have resting
Cl
currents (Valverde et al., 1994
;
Rouzaire-Dubois and Dubois, 1998
). This raises the possibility
that enhancement of basal Cl
currents is
an adaptation of malignant cells that contributes to tumor biology
[i.e., uncontrolled proliferation (Shen et al., 2000
) and invasive
migration (Soroceanu et al., 1999
)].
Cl
channels are vitally important for
cell volume regulation (O'Connor and Kimelberg, 1993
; Pasantes-Morales
et al., 1994
; Nilius et al., 1995
; Jackson and Madsen, 1997
;
Bond et al., 1998b
; Lang et al., 1998
; Mignen et al., 1999
;
Rouzaire-Dubois et al., 1999
; Valverde, 1999
; Xiong et al.,
1999
; Wang et al., 2000
) (but see Strange, 1988
). Ubiquitously
expressed volume-activated Cl
channels
are of particular importance for regulatory volume decreases (RVD).
During RVD, which cells undergo after swelling,
Cl
channels facilitate net salt efflux
(Cl
and K+
ions). Animal cells are endowed with water channels (aquaporins) that
keep them in osmotic equilibrium (Jackson and Madsen, 1997
; Lang et
al., 1998
). Therefore, channel-mediated net salt efflux is accompanied
by net water efflux leading to cell shrinkage-flattening. Passive,
channel-mediated salt efflux ultimately depends on membrane potential
and appropriate electrochemical gradients established by membrane
transporters. In addition to Cl
ions,
Cl
channels flux organic osmolytes such
as taurine (Kirk, 1997
). Channel-mediated shape-volume changes also
occur under isotonic conditions. For example, in cultured astrocytes,
induction of morphological changes is accompanied by chloride channel
activation (Lascola and Kraig, 1998
). In epithelial cells,
activation of K+ channels underlies
changes in cell volume during cell migration (Danker et al., 1996
;
Schwab et al., 1999
; Schneider et al., 2000
).
We hypothesize that in glioma cells, Cl
channels contribute to net salt fluxes underlying the shape-volume
changes requisite for glioma cell movement through the tortuous
extracellular space of brain (Soroceanu et al., 1999
). The invasive
migration of glioma cells into surrounding brain tissue complicates
surgical treatment (Adams and Victor, 1989
), hence, pharmacologic
inhibition of glioma Cl
channels may
have therapeutic benefits. Of course, our in vitro migration
assays are limited in assessing the complex biology underlying glioma
cell invasion. However, these assays do mimic the three-dimensional
spatial constraints encountered by invading glioma cells.
NPPB inhibited ICl,Vol
and transwell migration of glioma cells with almost identical
dose dependence (IC50 of 21 µM and 27 µM for
ICl,Vol and transwell migration,
respectively). These results suggest that the inhibitory effects of
NPPB on glioma migration were a consequence of
ICl,Vol inhibition and not of nonspecific interactions. NPPB did not lead to cell death because removal of NPPB after 4 hr rescued glioma cell migration in transwell assays. Our results with NPPB are consistent with the reduction of
glioma cell migration into fetal rat brain aggregates produced by
tamoxifen, which, like NPPB is a potent blocker of
ICl,Vol and the resting
Cl
conductance in glioma cells
(Soroceanu et al., 1999
). These data suggest that inhibition of
volume-activated Cl
channels will retard
the complex migration of glioma cells in brain as well as in the
simplified transwell assays.
Our data also suggest that ICl,Vol is
activated during cell movement. We obtained examples of clear
unidirectional cell movements that were accompanied by activation of
NPPB-sensitive currents (Fig. 7). These currents shifted the reversal
potential closer to the Nernst equilibrium potential for chloride
(ECl), identifying them as
Cl
currents. No spontaneous activation
was observed in cells that did not change shape or show cell movements
during the recording period. These observations support our hypothesis
that chloride currents are activated during cell movement.
Model of chloride channel involvement in invasive migration of
glioma cells
In the following section we develop a model for the invasive
migration of glioma cells that is consistent with our results (Fig.
8). We propose that invasive migration of
glioma cells requires shape and-or volume changes permissive for cell
movements through narrow extracellular spaces in brain. Electron
microscopic evidence supports the occurrence of such shape changes in
migrating glioma cells (Soroceanu et al., 1999
). We hypothesize that
chloride channel activation leads to Cl
efflux at typical resting potentials that is coupled to cation and
water efflux causing cell shrinkage. This requires that glioma cells
actively import Cl
ions [depicted as an
unidentified Cl
transporter (X) in Fig.
8A] to keep the equilibrium potential for
Cl
positive to the resting potential,
thereby providing a driving force for Cl
efflux. The inhibition of inward currents by NPPB during
perforated-patch recordings at typical resting potentials (
40 mV)
supports this assumption. The identity of the primary
[Cl
]i-regulating
transporter in glioma cells remains to be shown. Our model also depicts
activation of chloride and potassium channels at the leading edge of a
migrating glioma cell. The opening of these channels results in
cellular salt and water loss and cell shrinkage, permitting a
flattening of the leading edge and its extension through narrow
extracellular spaces (Fig. 8B). Our data suggest that
the Cl
channels activated during glioma
migration are NPPB-sensitive volume-activated
Cl
channels. We favor mechanical
activation of chloride currents during migration, as seen in neuronal
growth cones (Imai et al., 2000
), because kinase inhibition, prevention
of intracellular Ca2+ rises, and actin
stabilization did not prevent ICl,Vol
activation. The cation flux depicted in our model is most likely
accomplished by large-conductance
Ca2+-activated
K+ (BK) channels that are highly expressed
in these cells (Ransom and Sontheimer, 2001
). Consistent with this
assumption, pharmacological inhibition of BK channels with TEA (1 mM) also inhibits glioma cell transwell migration
(Soroceanu et al., 1999
). Ca2+-activated
K+ channels have been implicated in the
migration of other cell types (Danker et al., 1996
; MacLeod and
Hamilton, 1999
; Schwab et al., 1999
; Schneider et al., 2000
), and
migrating cells experience intracellular
Ca2+ increases required for BK activation
(Brundage et al., 1991
; Komuro and Rakic, 1996
). Possible
scenarios for ion channel participation in glioma cell
migration would include coactivation of BK and ICl,Vol, perhaps at discrete parts of
cells (i.e., leading edge), to induce cell shrinkage. Our results
suggest that Cl
channels will be
activated above basal levels during migratory events (Fig. 7). However,
one consequence of the resting Cl
conductance in glioma cells is that net salt flux (and subsequent shape-volume change) could be triggered by
K+ channel activation alone.

View larger version (37K):
[in this window]
[in a new window]
|
Figure 8.
Schematic of glioma cell membrane machinery
involved in shape-volume change. A, Intracellular
[Cl ] is actively regulated to produce
Cl efflux at typical resting membrane potentials
by an unknown mechanism [illustrated here as an unidentified
transporter (X)]. Operation of
[Cl ]i regulating proteins ultimately
depends on electrochemical gradients established by the
Na+/K+-ATPase. Activation of
Cl channels results in Cl
efflux, with accompanying cations and water, leading to cell
shrinkage-flattening. B, Shrinkage may only occur at
the leading edge or invading process and may be transient.
Actin-myosin molecular motors provide the forces necessary for cell
invasion, with cell volume changes acting primarily in a permissive
way.
|
|
Clearly, cell shrinkage alone is insufficient to permit cell invasion.
Importantly, actin-myosin molecular motors propel cells, and in the
process cytoskeletal rearrangements must occur to allow shape-volume
changes (Maidment, 1997
). In glioma cells, as in other cancerous cells,
matrix metalloproteinase degradation of extracellular matrix plays an
important role in invasion (Belien et al., 1999
). In addition, it has
been proposed that glioma cells may create room for their growth by
killing surrounding neurons through the release of excitotoxic
glutamate (Ye and Sontheimer, 1999
; Ye et al., 1999
). Glutamate
release may occur by reversed operation of cystine-glutamate exchange
or via the same channels we are proposing to be activated during cell
movement (Roy, 1995
; Phillis et al., 1998
; Basarsky et al., 1999
; Ye
and Sontheimer, 1999
; Ye et al., 1999
). Thus, multiple avenues
exist by which Cl
channel activity could
contribute to glioma cell migration and invasion. Given the complexity
of cell migration in brain, we suggest that
Cl
channel-mediated shape-volume
changes serve a permissive role in the movement of cells along narrow
migratory pathways. Cl
channels may
function similarly in other motile cells, including fibroblasts,
macrophages, microglia, and neural progenitor cells.
In summary, we have found that human glioma cells, in contrast to
normal rodent astrocytes, have a resting conductance dominated by
Cl
channels. Experiments with
amphotericin perforated patches demonstrated that glioma cells
distribute Cl
ions to produce
Cl
efflux at typical resting membrane
potentials. We suggest that resting Cl
currents are mediated by volume-activated
Cl
channels on the basis of the similar
properties of Cl
currents under isotonic
and hypotonic conditions. Pharmacologic inhibition of volume-activated
Cl
channels reduced migration of glioma
cells through 8 µm pores. Our data are consistent with the hypothesis
that volume-activated Cl
channels
contribute to the shape-volume changes required for movement of glioma
cells through narrow migratory pathways. The resting
Cl
conductance may be a positive
adaptation that contributes to the invasive behavior of glioma cells.
 |
FOOTNOTES |
Received March 12, 2001; revised July 13, 2001; accepted July 20, 2001.
This work was supported by National Institutes of Health Grant
RO1NS36692, American Cancer Society Grant ACS-RPG-083-01CDD, and a
Medical Scientist Training Program scholarship (C.B.R.).
Correspondence should be addressed to Dr. Harald Sontheimer, Department
of Neurobiology, University of Alabama at Birmingham, 1719 Sixth
Avenue, S CIRC 545, Birmingham, AL 35294. E-mail:
hws{at}nrc.uab.edu.
 |
REFERENCES |
-
Adams RD,
Victor M
(1989)
In: Principles of neurology, Ed 4. New York: McGraw-Hill.
-
Bakhramov A,
Fenech C,
Bolton TB
(1995)
Chloride current activated by hypotonicity in cultured human astrocytoma cells.
Exp Physiol
80:373-389[Abstract].
-
Basarsky TA,
Feighan D,
MacVicar BA
(1999)
Glutamate release through volume-activated channels during spreading depression.
J Neurosci
19:6439-6445[Abstract/Free Full Text].
-
Belien ATJ,
Paganetti PA,
Schwab ME
(1999)
Membrane type-1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter.
J Cell Biol
144:373-384[Abstract/Free Full Text].
-
Bond TD,
Ambikapathy S,
Mohammed S,
Valverde MA
(1998a)
Osmosensitive Cl
currents and their relevance to regulatory volume decrease in human intestinal T84 cells: outwardly vs. inwardly rectifying currents.
J Physiol (Lond)
511:45-54[Abstract/Free Full Text]. -
Bond TD,
Valverde MA,
Higgins CF
(1998b)
Protein kinase C phosphorylation disengages human and mouse 1a-P-glycoproteins from influencing the rate of activation of swelling-activated chloride currents.
J Physiol (Lond)
508:333-340[Abstract/Free Full Text].
-
Bordey A,
Sontheimer H
(1997)
Postnatal development of ionic currents in rat hippocampal astrocytes in situ.
J Neurophysiol
78:461-477[Abstract/Free Full Text].
-
Brismar I,
Collins VP
(1988)
Inward K-current in human malignant glioma cells: possible mechanism for K-homeostasis in the brain.
Acta Physiol Scand
132:259-260[Medline].
-
Brundage RA,
Fogarty KE,
Tuft RA,
Fay FS
(1991)
Calcium gradients underlying polarization and chemotaxis of eosinophils.
Science
254:703-706[Abstract/Free Full Text].
-
Cone CD
(1970)
Variation of the transmembrane potential level as a basic mechanism of mitosis control.
Oncogenesis
24:438-470.
-
Crepel V,
Panenka W,
Kelly ME,
MacVicar BA
(1998)
Mitogen-activated protein and tyrosine kinases in the activation of astrocyte volume-activated chloride current.
J Neurosci
18:1196-1206[Abstract/Free Full Text].
-
Danker T,
Gassner B,
Oberleithner H,
Schwab A
(1996)
Extracellular detection of K+ release during migration of transformed Madin-Darby canine kidney cells.
Pflügers Arch
433:71-76[ISI][Medline].
-
Diaz M,
Valverde MA,
Higgins CF,
Rucareanu C,
Sepulveda FV
(1993)
Volume-activated chloride channels in HeLa cells are blocked by verapamil and dideoxyforskolin.
Pflügers Arch
422:347-353[ISI][Medline].
-
Duan D,
Winter C,
Cowley S,
Hume JR,
Horowitz B
(1997)
Molecular identification of a volume-activated chloride channel.
Nature
390:417-421[Medline].
-
Duan D,
Cowley S,
Horowitz B,
Hume JR
(1999)
A serine residue links phosphorylation-dephosphorylation to chloride channel regulation by cell volume.
J Gen Physiol
113:57-70[Abstract/Free Full Text].
-
Hamill OP,
Marty A,
Neher E,
Sakmann B,
Sigworth FJ
(1981)
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
Pflügers Arch
391:85-100[ISI][Medline].
-
Hille B
(1992)
In: Ionic channels of excitable membranes. Sunderland, MA: Sinauer.
-
Imai K,
Tatsumi H,
Katayama Y
(2000)
Mechanosensitive chloride channels on the growth cones of cultured rat dorsal root ganglion neurons.
Neuroscience
97:347-355[ISI][Medline].
-
Jackson PS,
Madsen JR
(1997)
Cerebral edema, cell volume regulation, and the role of organic osmolyte transport.
Pediatr Neurosurg
27:279-285[ISI][Medline].
-
Kettenmann H,
Sonnhof U,
Schachner M
(1983)
Exclusive potassium dependence of the membrane potential in cultured mouse oligodendrocytes.
J Neurosci
3:500-505[Abstract].
-
Kirk KL
(1997)
Swelling-activated organic osmolyte channels.
J Membr Biol
158:1-16[ISI][Medline].
-
Kofuji P,
Ceelen P,
Zahs KR,
Surbeck LW,
Lester HA,
Newman EA
(2000)
Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina.
J Neurosci
20:5733-5740[Abstract/Free Full Text].
-
Komuro H,
Rakic P
(1996)
Intracellular Ca2+ fluctuations modulate the rate of neuronal migration.
Neuron
17:275-285[ISI][Medline].
-
Lang F,
Busch GL,
Ritter M,
Volkl H,
Waldegger S,
Gulbins E,
Haussinger D
(1998)
Functional significance of cell volume regulatory mechanisms.
Physiol Rev
78:247-306[Abstract/Free Full Text].
-
Lascola CD,
Kraig RP
(1996)
Whole-cell chloride currents in rat astrocytes accomp